Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10137 - 10144 of 11617 results
Tri-Agency Health IT Report Issued
April 3, 2014| Blog| Viewpoint
SEC Enforcement Staff's Investigations of Financially Stressed Municipal Issuers
April 3, 2014| Blog| Viewpoint
Provisions of Interest to Labs in the Protecting Access to Medicare Act of 2014
April 2, 2014| Blog| Viewpoint
An Update on the Regulatory and Legislative Efforts Regarding Bitcoins: A Security? A Commodity?
April 2, 2014| Blog| Viewpoint
ML Strategies' Energy and Environment Weekly Update - Week of March 31, 2014
April 1, 2014| Blog| Viewpoint
Compliance is No Joke: OCR Releases Security Risk Assessment Tool
April 1, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.